The Awards, which are in their 9th year, celebrate the best of UK life sciences - from outstanding scientific innovation within biotech, medtech, digital, synthetic biology, to the companies that support the industry and the fundraisers that make it happen. They were presented at the Town Hall in Oxford on 5th October.
Oxford Endovascular, a University of Oxford spin-out company, won the category for 'Best Start-up Medtech'. The company is developing a tiny mesh tube device to treat brain aneurisms. James Byrne, a Professor of Neuroradiology at the John Radcliffe Hospital, and Professor Zhong You in the Department of Engineering Science designed the device after observing the limitations of existing treatments.
The University of Oxford, Oxford University Innovation, Oxford University Hospitals NHS Foundation Trust and Drayson Technologies won in the 'Best Public-Private Collaboration' category. Drayson Technologies have signed an agreement to evaluate, develop and commercialise digital health applications including GDm-Health for the management of gestational diabetes, EDGE-COPD, a software system for the management of chronic obstructive pulmonary disease, and SEND, a system for vital-sign observations in hospital patients (blood pressure, heart rate, breathing rate, oxygen saturation and temperature) and risk score estimation. The applications are based on the research of Professor Lionel Tarassenko in the Department of Engineering Science working in collaboration with Oxford University Hospitals NHS Foundation Trust.
OBN is a UK not-for-profit membership organisation supporting and bringing together the UK's life sciences companies, corporate partners and investors.
Full story on the OBN Awards: http://obn.org.uk/News/Latest-News/entryid/1142